Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer’s disease and cardiovascular disease.

作者: I J Martins , E Hone , J K Foster , S I Sünram-Lea , A Gnjec

DOI: 10.1038/SJ.MP.4001854

关键词:

摘要: High fat diets and sedentary lifestyles are becoming major concerns for Western countries. They have led to a growing incidence of obesity, dyslipidemia, high blood pressure, condition known as the insulin-resistance syndrome or metabolic syndrome. These health conditions well develop along with, be precursors atherosclerosis, cardiovascular disease, diabetes. Recent studies found that most these disorders can also linked an increased risk Alzheimer's disease (AD). To complicate matters, possession one more apolipoprotein E epsilon4 (APOE epsilon4) alleles further increases severity many conditions, including AD. ApoE has roles in cholesterol metabolism Abeta clearance, both which thought significant AD pathogenesis. The apparent inadequacies may explain subjects carrying APOE alleles. This review describes some physiological biochemical changes above cause, how they related A diversity topics is covered, metabolism, glucose regulation, diabetes, insulin, function, amyloid precursor protein particular their relevance It seen abnormal lipid, consistently indicated central pathophysiology, possibly pathogenesis As diagnosis mild cognitive impairment early reliable, evidence accumulating such coronary artery factors AD, appropriate will likely reduce risk, improve prognosis people already suffering from conditions.

参考文章(240)
Marco RACCHI, Roberta BAETTA, Nathalie SALVIETTI, Paola IANNA, Guido FRANCESCHINI, Rodolfo PAOLETTI, Remo FUMAGALLI, Stefano GOVONI, Marco TRABUCCHI, Maurizio SOMA, Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochemical Journal. ,vol. 322, pp. 893- 898 ,(1997) , 10.1042/BJ3220893
E M Castano, F Prelli, T Wisniewski, A Golabek, R A Kumar, C Soto, B Frangione, Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. Biochemical Journal. ,vol. 306, pp. 599- 604 ,(1995) , 10.1042/BJ3060599
Daniela C. Solano, Marita Sironi, Claudia Bonfini, S. Bruno Solerte, Stefano Govoni, Marco Racchi, Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway The FASEB Journal. ,vol. 14, pp. 1015- 1022 ,(2000) , 10.1096/FASEBJ.14.7.1015
Y Hatanaka, K Kamino, K Fukuo, N Mitsuda, Y Nishiwaki-Ueda, N Sato, T Satoh, H Yamamoto, H Yoneda, M Imagawa, T Miki, S Ohta, T Ogihara, Low density lipoprotein receptor-related protein gene polymorphisms and risk for late-onset Alzheimer's disease in a Japanese population. Clinical Genetics. ,vol. 58, pp. 319- 323 ,(2000) , 10.1034/J.1399-0004.2000.580410.X
Giovanna Chimini, Michael Dean, Yannick Hamon, The human ATP-binding cassette (ABC) transporter superfamily Journal of Lipid Research. ,vol. 42, pp. 1007- 1017 ,(2001) , 10.1016/S0022-2275(20)31588-1
K A Jellinger, Traumatic brain injury as a risk factor for Alzheimer’s disease Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 75, pp. 511- 512 ,(2004)
Laura Gasparini, Gunnar K Gouras, Rong Wang, Rachel S Gross, M Flint Beal, Paul Greengard, Huaxi Xu, None, Stimulation of β-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal β-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling The Journal of Neuroscience. ,vol. 21, pp. 2561- 2570 ,(2001) , 10.1523/JNEUROSCI.21-08-02561.2001
Steven Bodovitz, William L. Klein, Cholesterol Modulates α-Secretase Cleavage of Amyloid Precursor Protein Journal of Biological Chemistry. ,vol. 271, pp. 4436- 4440 ,(1996) , 10.1074/JBC.271.8.4436